Navigation Links
ResMed Inc. Announces Record Financial Results For The Quarter Ended And Nine Months Ended March 31, 2013
Date:4/25/2013

ion Reform Act of 1995. These forward-looking statements, including statements regarding the company's future revenue, earnings or expenses, new product development, new product launches, and new markets for the company's products, are subject to risks and uncertainties, which could cause actual results to materially differ from those projected or implied in the forward-looking statements. Those risks and uncertainties are discussed in the company's Annual Report on Form 10-K for its most recent fiscal year and in other reports the company files with the U.S. Securities & Exchange Commission.  Those reports are available on the company's website.ResMed Inc and SubsidiariesCondensed Consolidated Statements of Income (Unaudited)(In US$ thousands, except per share data)Three Months Ended

March 31,

Nine Months Ended

March 31,2013

2012

2013

2012Net revenue

$383,581

$349,073

$1,099,850

$996,586Cost of sales

144,132

138,577

419,041

402,320Gross profit

239,449

210,496

680,809

594,266Operating expenses:Selling, general and administrative

109,628

101,958

315,745

296,712Research and development

31,189

28,398

88,735

81,822Amortization of acquired intangible assets

2,533

3,592

7,671

11,055Total operating expenses'/>"/>

SOURCE ResMed Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8

Related medicine technology :

1. ResMed Noninvasive Ventilation Device Cleared by FDA for COPD Treatment
2. ResMed Announces Conference Call And Webcast To Discuss Third Quarter 2013 Results
3. ResMed Takes Action to Enforce Patents
4. Buoyed by Forecasts, Where 2013 Leads - Research Report on ResMed Inc., Zimmer Holdings, Inc., Waters Corporation, Covidien PLC, and Medtronic, Inc.
5. ResMed Inc. Announces Record Financial Results For The Quarter Ended And Six Months Ended December 31, 2012
6. ResMed Inc. Announces Exchange Rate For Upcoming Dividend Payment
7. ResMed Inc. Announces Record Financial Results for the Quarter Ended September 30, 2012
8. ResMed Inc. Announces Record Financial Results For The Quarter And Twelve Months Ended June 30, 2012
9. ResMed Announces Conference Call And Webcast To Discuss Fourth Quarter And Fiscal Year-End 2012 Results
10. ResMed Launches Narval™ CC Mandibular Repositioning Device in the US
11. ResMed Inc. Announces Plan To Initiate Dividend And Update On Chief Executive Officer Succession
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/22/2015)... , May 22, 2015 The Assistance Fund ... This program provides financial assistance for copay to individuals ... to announce the addition of the Melanoma Copay Assistance ... Mark McGreevy , executive director. "With each additional program ... of a world where no one is denied access ...
(Date:5/22/2015)... , May 22, 2015  RegeneRx Biopharmaceuticals, Inc. ... tissue protection, repair and regeneration, today announced that ... scheduled to present a corporate overview at two upcoming ... at the SeeThruEquity 4 th Annual Microcap Conference ... York City at 11:00 am EDT.  A ...
(Date:5/22/2015)...  The Mesothelioma Victims Center is incredibly passionate ... the best possible compensation, and they are also extremely ... cancer caused by exposure to asbestos or their ... treatment options such as a recent possible medical breakthrough. ... Center anytime at 866-714-6466. http://MesotheliomaVictimsCenter.Com ...
Breaking Medicine Technology:The Assistance Fund Adds Melanoma Assistance Program 2RegeneRx to Present at 2 Investor Conferences 2RegeneRx to Present at 2 Investor Conferences 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 2Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 3Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 4Mesothelioma Victims Center Calls Attention to a Recent Medical Article About a New Drug That Could Slow the Progression of Mesothelioma and Allow People to Live Longer 5
... Chindex International, Inc. (NASDAQ: CHDX ), ... China through the operations of United Family Healthcare, a network ... announced financial results for the third quarter and first nine ... Third Quarter 2011 Financial Highlights ...
...  Inova Labs, a privately held medical ... Chronic Obstructive Pulmonary Disease (COPD) market, announced today that ... financing for up to $17.5M from an investment syndicate ... Calif. The company plans to use the capital to ...
Cached Medicine Technology:Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 2Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 3Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 4Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 5Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 6Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 7Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 8Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 9Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 10Chindex International, Inc. Reports Financial Results for the Third Quarter and First Nine Months of 2011 11Inova Labs Closes on $17.5M Series B Financing 2
(Date:5/23/2015)... On May 16, the team at ... a 5k mud obstacle run that raised funds for multiple ... worldwide, and the reason we participated was to support people ... of Farrell’s eXtreme Bodyshaping. “One-hundred percent of the funds raised ... event was not only attended by eXtreme Bodyshaping staff, but ...
(Date:5/23/2015)... (PRWEB) May 23, 2015 A live auction ... equipment from hospitals, surgery centers and other medical facilities around ... sold including endoscopy, lab, radiology, surgery, anesthesia, exam and much ... May 27 and Thursday, May 28 starting at 9:00am CDT ... at 1400 N. 25th Avenue, Melrose Park, IL 60160. ...
(Date:5/23/2015)... Add High-Quality prismatic refractions into footage using ProFlare ... simple as dragging and dropping footage into the FCPX timeline ... , Including over 80 stunning flares, ProFlare 5K Prism ... the ultimate bundle for adding prismatic refractions to any video. ... movie files designed for Final Cut Pro X, but are ...
(Date:5/22/2015)... May 22, 2015 The world ... and capacity are intersecting to create new opportunities ... the opening speaker at WesternU's 34th annual Commencement ... Gov. Gavin Newsom, a former San Francisco mayor ... speaker at the graduation ceremony for WesternU's colleges ...
(Date:5/22/2015)... 2015 The American College of Traditional ... June. They will hold a webinar on the updates ... class on Classical Chinese Medicine. , Webinar – First ... Given, the Dean of Clinical Education, will lead this ... Professional Doctorate program. ACTCM is currently developing this degree ...
Breaking Medicine News(10 mins):Health News:Farrell’s eXtreme Bodyshaping Team Runs through the Muck for MS 2Health News:Over 5,200 Lots of Medical Equipment Will Be Sold by Live Auction 2Health News:Developers at Pixel Film Studios Release ProFlare 5K Prism for Final Cut Pro X. 2Health News:Newsom to WesternU Grads: The Future is Inside You 2Health News:Newsom to WesternU Grads: The Future is Inside You 3Health News:ACTCM Announces Upcoming June Events 2
... with muscle-thickening disorder may also identify children at risk ... 10 gene mutations responsible for cardiac hypertrophy (thickening of ... many cases of this rare but life-threatening condition in ... showed up in children who had no family history ...
... Muneo Takashi has been,named to head the Chicago ... As the new Chief Executive Director, Takashi follows ... assignment in Chicago., As Chief Executive Director, ... activities designed to facilitate business development,between Japan and ...
... Tripled dose was ineffective and toxic, so strategy should ... News) -- High-intensity chemotherapy does not improve the survival ... a new Swiss study concludes. , Testing on 140 ... differences in survival rate or tumor size between groups ...
... Researchers at Boston College have developed the first laboratory ... Using their novel cell line, the team discovered one of ... attack. , The development of a new animal model ... that displays the full spectrum of systemic metastatic cancer ...
... remains,underdiagnosed and undertreated even though this neurologic ... options have increased in the,last decade., ... treat this neurologic,sleep disorder, The Journal of ... supplement "Stay awake! Understanding, diagnosing, and,successfully managing ...
... 9 United Heartland is pleased to,announce that ... of,Community Providers has earned a record dividend of ... performance of the group,s 48 members, which,achieved an ... http://www.newscom.com/cgi-bin/prnh/20080409/CLW076LOGO ), The Iowa Association of ...
Cached Medicine News:Health News:Gene Mutations for Rare Heart Disease Also Found in Kids 2Health News:Muneo Takashi Named Chief Executive Director of Japan's Midwest Trade Office 2Health News:High-Dose Chemo Fails Against Small Cell Lung Cancers 2Health News:Boston College biologists build a better mouse model for cancer research 2Health News:United Heartland Group Program Earns Record Dividend 2
Bailey lachrymal cannula, 7 mm exposed tip, 8 mm reinforced....
Lachrymal cannula, straight....
Shahinian lacrimal cannula, bullet shaped tip, 0.3 mm side opening, straight....
Solo-care is a multi-purpose solution for cleaning, rinsing, disinfection and storing soft contact lenses....
Medicine Products: